Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Maria De Santis; Joaquim Bellmunt; Graham Mead; J Martijn Kerst; Michael Leahy; Pablo Maroto; Thierry Gil; Sandrine Marreaud; Gedske Daugaard; Iwona Skoneczna; Sandra Collette; Julie Lorent; Ronald de Wit; Richard Sylvester

doi:10.1200/JCO.2011.37.3571

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Maria De Santis, Joaquim Bellmunt, Graham Mead, J Martijn Kerst, Michael Leahy, Pablo Maroto, Thierry Gil, Sandrine Marreaud, Gedske Daugaard, Iwona Skoneczna, Sandra Collette, Julie Lorent, Ronald de Wit, Richard Sylvester

678 Citationer (Scopus)

Abstract

This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ("unfit") for cisplatin chemotherapy.

Originalsprog	Engelsk
Tidsskrift	Journal of Clinical Oncology
Vol/bind	30
Udgave nummer	2
Sider (fra-til)	191-9
Antal sider	9
ISSN	0732-183X
DOI	https://doi.org/10.1200/JCO.2011.37.3571
Status	Udgivet - 2012

Adgang til dokumentet

10.1200/JCO.2011.37.3571

Andre filer og links

Link to publication in Scopus

Fingeraftryk

Dyk ned i forskningsemnerne om 'Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986'. Sammen danner de et unikt fingeraftryk.

Citationsformater

De Santis, M., Bellmunt, J., Mead, G., Kerst, J. M., Leahy, M., Maroto, P., Gil, T., Marreaud, S., Daugaard, G., Skoneczna, I., Collette, S., Lorent, J., de Wit, R., & Sylvester, R. (2012). Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of Clinical Oncology, 30(2), 191-9. https://doi.org/10.1200/JCO.2011.37.3571

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. / De Santis, Maria; Bellmunt, Joaquim; Mead, Graham et al.
I: Journal of Clinical Oncology, Bind 30, Nr. 2, 2012, s. 191-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

De Santis, M, Bellmunt, J, Mead, G, Kerst, JM, Leahy, M, Maroto, P, Gil, T, Marreaud, S, Daugaard, G, Skoneczna, I, Collette, S, Lorent, J, de Wit, R & Sylvester, R 2012, 'Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986', Journal of Clinical Oncology, bind 30, nr. 2, s. 191-9. https://doi.org/10.1200/JCO.2011.37.3571

@article{9871b6c3d7b14f328b4c0b94fe8fa505,

title = "Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986",

abstract = "This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ({"}unfit{"}) for cisplatin chemotherapy.",

keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Cisplatin, Deoxycytidine, Female, Humans, Male, Methotrexate, Middle Aged, Quality of Life, Questionnaires, Survival Rate, Urologic Neoplasms, Vinblastine",

author = "\{De Santis\}, Maria and Joaquim Bellmunt and Graham Mead and Kerst, \{J Martijn\} and Michael Leahy and Pablo Maroto and Thierry Gil and Sandrine Marreaud and Gedske Daugaard and Iwona Skoneczna and Sandra Collette and Julie Lorent and \{de Wit\}, Ronald and Richard Sylvester",

year = "2012",

doi = "10.1200/JCO.2011.37.3571",

language = "English",

volume = "30",

pages = "191--9",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy

T2 - EORTC study 30986

AU - De Santis, Maria

AU - Bellmunt, Joaquim

AU - Mead, Graham

AU - Kerst, J Martijn

AU - Leahy, Michael

AU - Maroto, Pablo

AU - Gil, Thierry

AU - Marreaud, Sandrine

AU - Daugaard, Gedske

AU - Skoneczna, Iwona

AU - Collette, Sandra

AU - Lorent, Julie

AU - de Wit, Ronald

AU - Sylvester, Richard

PY - 2012

Y1 - 2012

N2 - This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ("unfit") for cisplatin chemotherapy.

AB - This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ("unfit") for cisplatin chemotherapy.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carboplatin

KW - Cisplatin

KW - Deoxycytidine

KW - Female

KW - Humans

KW - Male

KW - Methotrexate

KW - Middle Aged

KW - Quality of Life

KW - Questionnaires

KW - Survival Rate

KW - Urologic Neoplasms

KW - Vinblastine

UR - https://www.scopus.com/pages/publications/84855583390

U2 - 10.1200/JCO.2011.37.3571

DO - 10.1200/JCO.2011.37.3571

M3 - Journal article

C2 - 22162575

SN - 0732-183X

VL - 30

SP - 191

EP - 199

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 2

ER -